has been cited by the following article(s):
|
[1]
|
Érythème noueux associé au vaccin Tozinaméran: à propos de 2 cas et revue de la littérature
|
|
Therapie,
2023 |
|
|
|
|
[2]
|
Erythema nodosum associated with COVID19 infection: A pediatric case report and review of the literature
|
|
Pediatric Dermatology,
2023 |
|
|
|
|
[3]
|
SARS-CoV2 vaccination-induced erythema nodosum: A case report
|
|
Journal of Pakistan …,
2023 |
|
|
|
|
[4]
|
Erythema nodosum after COVID‐19 vaccine: Report of two pediatric cases
|
|
Pediatric …,
2022 |
|
|
|
|
[5]
|
Erythčme noueux associé au vaccin Tozinaméran: ā propos de 2 cas et revue de la littérature
|
|
Therapies,
2022 |
|
|
|
|
[6]
|
Covid‐19 vaccine associated erythema nodosum: Factors to consider.
|
|
Dermatologic Therapy,
2022 |
|
|
|
|
[7]
|
Erythema nodosum associated with Tozinameran vaccine: Report of 2 cases and review of the literature
|
|
Therapie,
2022 |
|
|
|
|
[8]
|
Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis
|
|
The Egyptian Journal of Internal Medicine,
2022 |
|
|
|
|
[9]
|
Covid‐19 vaccine associated erythema nodosum: Factors to consider
|
|
Dermatologic Therapy,
2022 |
|
|
|
|
[10]
|
Erythema nodosum, after Medigen vaccination against COVID-19?
|
|
Journal of the Formosan Medical …,
2022 |
|
|
|
|
[11]
|
Atypical presentation of erythema nodosum following Pfizer-BioNTech COVID-19 vaccine
|
|
Medical …,
2022 |
|
|
|
|
[12]
|
Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine
|
|
Vaccine,
2022 |
|
|
|
|
[1]
|
Complications After Exosome Treatment for Aesthetic Skin Rejuvenation
Dermatological Reviews,
2024
DOI:10.1002/der2.242
|
|
|
|
|
[2]
|
Erythema nodosum, after Medigen vaccination against COVID-19?
Journal of the Formosan Medical Association,
2022
DOI:10.1016/j.jfma.2021.10.002
|
|
|
|
|
[3]
|
Immune-mediated adverse events post-COVID vaccination and types of vaccines: a systematic review and meta-analysis
The Egyptian Journal of Internal Medicine,
2022
DOI:10.1186/s43162-022-00129-5
|
|
|
|
|
[4]
|
Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine
Vaccine,
2022
DOI:10.1016/j.vaccine.2022.03.052
|
|
|
|
|
[5]
|
Érythème noueux associé au vaccin Tozinaméran : à propos de 2 cas et revue de la littérature
Therapies,
2022
DOI:10.1016/j.therap.2022.06.002
|
|
|
|
|
[6]
|
Erythema nodosum associated with
COVID19
infection: A pediatric case report and review of the literature
Pediatric Dermatology,
2022
DOI:10.1111/pde.15096
|
|
|
|
|
[7]
|
Covid‐19 vaccine associated erythema nodosum: Factors to consider
Dermatologic Therapy,
2022
DOI:10.1111/dth.15410
|
|
|
|
|
[8]
|
Erythema nodosum after
COVID
‐19 vaccine: Report of two pediatric cases
Pediatric Dermatology,
2022
DOI:10.1111/pde.15205
|
|
|
|